Grifols (GRFS) Operating Expenses (2011 - 2023)
Grifols (GRFS) reported Operating Expenses of $51636.5 for Q4 2023, up 753.49% on a YoY basis from $6050.1 in Q4 2022, and up 753.49% quarter-over-quarter from $6050.1 in Q4 2022.
Grifols (GRFS) Operating Expenses (2011 - 2023) Analysis & Trends
Grifols has reported Operating Expenses for 11 years, with the latest figure at $51636.5 in Q4 2023.
- For the quarter ending Q4 2023, Operating Expenses rose 753.49% year-over-year to $51636.5; the trailing twelve-month figure through Dec 2025 stood at $57686.6 (changed 0.0% YoY), and the FY2025 full-year result was $1.9 billion, up 6.94% from the prior year.
- Operating Expenses for Q4 2023 stood at $51636.5, up from $6050.1 in the prior quarter.
- The five-year high for Operating Expenses was $51636.5 in Q4 2023, with the low at -$993.1 million in Q4 2019.
- Historically, Operating Expenses has averaged -$336.4 million across 4 years, with a median of -$337.5 million in 2019.
- Annual changes were most pronounced in 2019 — Operating Expenses slipped 14.7% — and 2023, when it surged 753.49%.
- Grifols' Operating Expenses stood at -$993.1 million in 2019, then soared by 64.6% to -$351.5 million in 2020, then soared by 100.0% to $6050.1 in 2022, then surged by 753.49% to $51636.5 in 2023.
- The last three Operating Expenses figures came in at $51636.5 (Q4 2023), $6050.1 (Q4 2022), and -$351.5 million (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -5.14 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 6.72 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 9.59 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 11.01 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 19.82 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 5.95 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 4.37 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 5.50 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 8.25 Bn |
| 10 | Grifols | 6.05 Bn | 5.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 51,636.51 |
| Dec 31, 2022 | 6,050.07 |
| Mar 31, 2020 | -351.55 Mn |
| Dec 31, 2019 | -993.06 Mn |
| Mar 31, 2019 | -337.55 Mn |
| Dec 31, 2018 | -865.76 Mn |
| Jun 30, 2018 | 305.20 Mn |
| Mar 31, 2018 | -300.11 Mn |
| Dec 31, 2017 | -979.68 Mn |
| Jun 30, 2017 | 303.67 Mn |
| Mar 31, 2017 | -308.10 Mn |
| Dec 31, 2016 | 1.83 Bn |
| Sep 30, 2016 | 254.98 Mn |
| Jun 30, 2016 | 278.46 Mn |
| Dec 31, 2015 | 295.12 Mn |
| Sep 30, 2015 | 261.68 Mn |
| Jun 30, 2015 | 266.77 Mn |
| Mar 31, 2015 | -242.62 Mn |
| Sep 30, 2013 | 224.33 Mn |
| Jun 30, 2013 | 218.89 Mn |